Net Cash Provided by (Used in) Operating Activities in USD of INTERCEPT PHARMACEUTICALS, INC. from 2010 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
Summary
INTERCEPT PHARMACEUTICALS, INC. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and change rate from 2010 to Q1 2023.
  • INTERCEPT PHARMACEUTICALS, INC. Net Cash Provided by (Used in) Operating Activities for the quarter ending 31 Mar 2023 was -$51.6M, a 156% decline year-over-year.
  • INTERCEPT PHARMACEUTICALS, INC. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$26.8M, a 34.8% increase from 2021.
  • INTERCEPT PHARMACEUTICALS, INC. annual Net Cash Provided by (Used in) Operating Activities for 2021 was -$41.1M, a 76.1% increase from 2020.
  • INTERCEPT PHARMACEUTICALS, INC. annual Net Cash Provided by (Used in) Operating Activities for 2020 was -$172M, a 27.4% increase from 2019.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Change (%)

INTERCEPT PHARMACEUTICALS, INC. Quarterly Net Cash Provided by (Used in) Operating Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 -$51.6M -$31.5M -156% 01 Jan 2023 31 Mar 2023 10-Q 27 Apr 2023
Q1 2022 -$20.1M +$34.5M +63.2% 01 Jan 2022 31 Mar 2022 10-Q 27 Apr 2023
Q1 2021 -$54.7M +$44.1M +44.6% 01 Jan 2021 31 Mar 2021 10-Q 06 May 2022
Q1 2020 -$98.7M -$15.3M -18.3% 01 Jan 2020 31 Mar 2020 10-Q 06 May 2021
Q1 2019 -$83.4M +$5.44M +6.12% 01 Jan 2019 31 Mar 2019 10-Q 11 May 2020
Q1 2018 -$88.9M -$11.4M -14.7% 01 Jan 2018 31 Mar 2018 10-Q 08 May 2019
Q1 2017 -$77.5M 01 Jan 2017 31 Mar 2017 10-Q 10 May 2018
Q1 2015 -$29.6M -$17.3M -140% 01 Jan 2015 31 Mar 2015 10-Q 11 May 2015
Q1 2014 -$12.3M -$6.68M -119% 01 Jan 2014 31 Mar 2014 10-Q 11 May 2015
Q1 2013 -$5.64M -$1.74M -44.8% 01 Jan 2013 31 Mar 2013 10-Q 09 May 2014
Q1 2012 -$3.89M 01 Jan 2012 31 Mar 2012 10-Q 14 May 2013

INTERCEPT PHARMACEUTICALS, INC. Annual Net Cash Provided by (Used in) Operating Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$26.8M +$14.3M +34.8% 01 Jan 2022 31 Dec 2022 10-K 02 Mar 2023
2021 -$41.1M +$131M +76.1% 01 Jan 2021 31 Dec 2021 10-K 02 Mar 2023
2020 -$172M +$64.7M +27.4% 01 Jan 2020 31 Dec 2020 10-K 02 Mar 2023
2019 -$237M +$4.1M +1.7% 01 Jan 2019 31 Dec 2019 10-K 02 Mar 2022
2018 -$241M +$24.7M +9.3% 01 Jan 2018 31 Dec 2018 10-K 25 Feb 2021
2017 -$265M +$77M +22.5% 01 Jan 2017 31 Dec 2017 10-K 25 Feb 2020
2016 -$342M -$180M -110% 01 Jan 2016 31 Dec 2016 10-K 01 Mar 2019
2015 -$163M -$75.2M -85.7% 01 Jan 2015 31 Dec 2015 10-K 28 Feb 2018
2014 -$87.7M -$59.7M -213% 01 Jan 2014 31 Dec 2014 10-K 02 Mar 2015
2013 -$28M -$12.3M -77.8% 01 Jan 2013 31 Dec 2013 10-K 02 Mar 2015
2012 -$15.7M -$18.4M -704% 01 Jan 2012 31 Dec 2012 10-K 02 Mar 2015
2011 $2.61M +$16.3M 01 Jan 2011 31 Dec 2011 10-K 14 Mar 2014
2010 -$13.7M 01 Jan 2010 31 Dec 2010 10-K 01 Apr 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.